20+ hour, 18+ min ago   (1072+ words) An 18-month study of children with up to 5 nut allergies found that a 30-mg per-nut maintenance dose significantly improved tolerated doses without serious adverse events. A recent study showed that very low-dose oral immunology (VLOIT) significantly increased tolerated doses of…...

1+ day, 3+ hour ago   (1018+ words) A study found tahini was associated with lower reaction thresholds and higher anaphylaxis rates than whole seeds, suggesting it may better reflect true sesame allergy risk. In a recent study, outcomes of 307 pediatric sesame oral food challenges (OFC) varied by…...

2+ day, 3+ hour ago   (889+ words) A study links caregiver beliefs, mental health challenges, multiple allergens, and prior anaphylaxis to worse food allergy'related quality of life in pediatric patients. In children with food allergies, poorer quality of life is linked to internalizing mental health problems, parental…...

3+ day, 13+ min ago   (1079+ words) An age-based observational study in glomerular disease suggests different rates of disease progression and remission in young adults compared to adult and pediatric patients. New research suggests young adults with glomerular disease may experience different rates of relapse, kidney function…...

4+ day, 3+ hour ago   (961+ words) Q4 2025 brought key FDA approvals and phase 3 advances in HAE, peanut allergy, multi-allergen immunotherapy, and allergic fungal rhinosinusitis. In this recap, we spotlighted 8 allergy news stories published between October through December. The FDA approved berotralstat (ORLADEYO) oral pellets for children aged…...

1+ week, 5+ hour ago   (247+ words) December highlights: FDA approval of berotralstat for pediatric HAE, phase 3 RAPIDe-3 results, and allergy field spotlights in our This Year in Medicine series. For clinicians, December's updates underscore a broader shift toward more personalized, less burdensome care, particularly for pediatric…...

5+ mon, 1+ week ago   (300+ words) A new study highlights stress, concussion, and other early-life factors as key contributors to pediatric pain-predominant DGBIs. Beate Beinvogl, MD, MPH In this retrospective cross-sectional study, investigators sought to characterize the frequency and number of vulnerability factors for the development…...